NASDAQ:GLMD | Cash Flow Statement | Galmed Pharmaceuticals Ltd.

Complete source-backed cash-flow history.

Available history
2012-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$2.72M
2026-03-31-$1.91M
2025-12-31-$4.82M-$1.95M$1.43M$1.19M
2025-09-30-$1.89M
2025-06-30-$2.5M
2025-03-31-$1.1M
2024-12-31-$3.21M-$1.91M-$2.45M$448,000.00
2024-09-30-$1.91M
2024-06-30-$1.12M
2024-03-31-$1.28M
2023-06-30-$1.59M
2023-03-31-$1.83M
2022-06-30-$3.73M
2022-03-31-$6.14M
2021-06-30-$8.4M
2021-03-31-$8.91M
2020-06-30-$5.53M
2020-03-31-$6.06M
2019-06-30-$4.17M
2019-03-31-$3.49M
2018-06-30-$2.69M
2018-03-31-$2.51M
2017-06-30-$2.69M
2016-06-30-$4.31M
2015-06-30-$2.35M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$10.31M-$6.32M-$3.38M$9.03M
2024-12-31-$7.52M-$5.88M-$1.11M$8.79M
2023-12-31-$6.91M-$6.14M$800,000.00$6.19M
2022-12-31-$17.87M-$18.5M$4,000.00$17.56M$70,000.00
2021-12-31-$32.47M$42,000.00-$32.89M$11,000.00$11.46M$17.37M
2020-12-31-$28.77M$39,000.00-$26.29M$44,000.00$16.54M$768,000.00
2019-12-31-$20.46M$35,000.00-$14.94M$12,000.00$6.68M$143,000.00
2018-12-31-$9.86M$387,000.00-$9.02M$90,000.00-$60.02M$80.18M
2017-12-31-$12.3M$239,000.00-$12.07M$12,000.00$6.44M$15.55M
2016-12-31-$16.95M$169,000.00-$12.13M$17,000.00$6.34M$4.73M
2015-12-31-$10.62M$50,000.00-$8.47M$159,000.00-$11.11M$0.00
2014-12-31-$9.1M$9,000.00-$9.24M$770,000.00
2013-12-31-$17.49M$4,000.00-$2.52M$13,000.00
2012-12-31-$3.15M$5,000.00-$3.08M$32,000.00